Skip to main content
Log in

CTLA4 A49G Polymorphism Shows Significant Association With Glioma Risk in a Chinese Population

  • Published:
Biochemical Genetics Aims and scope Submit manuscript

Abstract

Cytotoxic T lymphocyte-associated antigen-4 (CTLA4) A49G is a polymorphism that is extensively studied in various cancers. To investigate whether it is associated with the occurrence of glioma in Chinese patients, we performed a case–control research study with 670 patients and 680 controls. In this group, we found that the genotype at this locus is significantly associated with glioma risk (GG vs. AA: P = 0.045; GG + AG vs. AA: P = 0.013). In some subgroups, G allele carriers are significantly less represented. We also observed significant correlations between the polymorphism genotype and glioma risk in patients with WHO histologic stages. We conclude that CTLA4 A49G might be a potential clinical biomarker for distinguishing persons with a high risk for developing gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Alegre ML, Frauwirth KA, Thompson CB (2001) T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 1(3):220–228

    Article  PubMed  CAS  Google Scholar 

  • Aloisi F, Ria F, Penna G, Adorini L (1998) Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol 160(10):4671–4680

    PubMed  CAS  Google Scholar 

  • Carson MJ, Sutcliffe JG, Campbell IL (1999) Microglia stimulate naive t-cell differentiation without stimulating T-cell proliferation. J Neurosci Res 55(1):127–134

    Article  PubMed  CAS  Google Scholar 

  • Egen JG, Kuhns MS, Allison JP (2002) CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 3(7):611–618

    Article  PubMed  CAS  Google Scholar 

  • Erfani N, Razmkhah M, Talei AR, Pezeshki AM, Doroudchi M, Monabati A, Ghaderi A (2006) Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Cancer Genet Cytogenet 165(2):114–120

    Article  PubMed  CAS  Google Scholar 

  • Flynn S, Stockinger B (2003) Tumor and CD4 T-cell interactions: tumor escape as result of reciprocal inactivation. Blood 101(11):4472–4478

    Article  PubMed  CAS  Google Scholar 

  • Ghaderi A, Yeganeh F, Kalantari T, Talei AR, Pezeshki AM, Doroudchi M, Dehaghani AS (2004) Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat 86(1):1–7

    Article  PubMed  CAS  Google Scholar 

  • Gomez GG, Kruse CA (2006) Mechanisms of malignant glioma immune resistance and sources of immunosuppression. Gene Ther Mol Biol 10(A):133–146

    PubMed  Google Scholar 

  • Hadinia A, Hossieni SV, Erfani N, Saberi-Firozi M, Fattahi MJ, Ghaderi A (2007) CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers. J Gastroenterol Hepatol 22(12):2283–2287

    Article  PubMed  CAS  Google Scholar 

  • Hunt KA, McGovern DP, Kumar PJ, Ghosh S, Travis SP, Walters JR, Jewell DP, Playford RJ, van Heel DA (2005) A common CTLA4 haplotype associated with coeliac disease. Eur J Hum Genet 13(4):440–444

    Article  PubMed  CAS  Google Scholar 

  • Hutchcroft JE, Bierer BE (1996) Signaling through CD28/CTLA-4 family receptors—puzzling participation of phosphatidylinositol-3 kinase. J Immunol 156(11):4071–4074

    PubMed  CAS  Google Scholar 

  • Jacobs JF, Idema AJ, Bol KF, Nierkens S, Grauer OM, Wesseling P, Grotenhuis JA, Hoogerbrugge PM, de Vries IJ, Adema GJ (2009) Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors. Neuro Oncol 11(4):394–402

    Article  PubMed  CAS  Google Scholar 

  • Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumours. Brain Pathol 3:255–268

    Article  PubMed  CAS  Google Scholar 

  • Kouki T, Sawai P, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of graves’ disease. J Immunol 165(11):6606–6611

    PubMed  CAS  Google Scholar 

  • Kulprathipanja NV, Kruse CA (2004) Microglia phagocytose alloreactive CTL-damaged 9L gliosarcoma cells. J Neuroimmunol 153(1–2):76–82

    Article  PubMed  CAS  Google Scholar 

  • Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J (2001) CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2(3):145–152

    Article  PubMed  CAS  Google Scholar 

  • Liu Y, Zhang H, Zhou K, Chen L, Xu Z, Zhong Y, Liu H, Li R, Shugart YY, Wei Q, Jin L, Huang F, Lu D, Zhou L (2007) Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Carcinogenesis 28(9):1906–1913

    Article  PubMed  CAS  Google Scholar 

  • Maeurer M, Loserth S, Kolb-Maeurer A, Ponath A, Wiese S, Kruse N, Rieckmann P (2002) A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 54(1):1–8

    Article  CAS  Google Scholar 

  • Merchant TE, Pollack IF, Loeffler JS (2010) Brain tumors across the age spectrum: biology, therapy, and late effects. Semin Radiat Oncol 20(1):58–66

    Article  PubMed  Google Scholar 

  • Monne M, Piras G, Palmas A, Arru L, Murineddu M, Latte G, Noli A, Gabbas A (2004) Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-hodgkin’s lymphoma. Am J Hematol 76(1):14–18

    Article  PubMed  CAS  Google Scholar 

  • Raffel C (1996) Molecular biology of pediatric gliomas. J Neurooncol 28(2–3):121–128

    PubMed  CAS  Google Scholar 

  • Rudd CE, Schneider H (2003) Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat Rev Immunol 3(7):544–556

    Article  PubMed  CAS  Google Scholar 

  • Schartner JM, Hagar AR, Van Handel M, Zhang LY, Nadkarni N, Badie B (2005) Impaired capacity for upregulation of MHC class II in tumor-associated microglia. Glia 51(4):279–285

    Article  PubMed  Google Scholar 

  • Sehgal A, Berger MS (2007) Basic concepts of immunology and neuroimmunology. Neurosurg Focus 9(6):e1

    Article  Google Scholar 

  • Sharpe AH, Freeman GJ (2002) The B7-CD28 superfamily. Nat Rev Immunol 2(2):116–126

    Article  PubMed  CAS  Google Scholar 

  • Su TH, Chang TY, Lee YJ, Chen CK, Liu HF, Chu CC, Lin M, Wang PT, Huang WC, Chen TC, Yang YC (2007) CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women. Carcinogenesis 28(6):1237–1240

    Article  PubMed  CAS  Google Scholar 

  • Sun T, Zhou YF, Yang M, Hu ZB, Tan W, Han XH, Shi YK, Yao JR, Guo YL, Yu DK, Tian T, Zhou XY, Shen HB, Lin DX (2008) Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res 68(17):7025–7034

    Article  PubMed  CAS  Google Scholar 

  • Tatter SB, Wilson CB, IV HarshGR (1995) Neuroepithelial tumors of the adult brain. In: Youmans JR (ed) Neurological surgery, 4th edn., vol. 4: Tumors. W. B. Saunders Co, Philadelphia, pp 2612–2684

    Google Scholar 

  • Ueda H, Howson JMM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KMD, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RCJ, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SCL (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423(6939):506–511

    Article  PubMed  CAS  Google Scholar 

  • Wang LH, Li DL, Fu ZK, Li H, Jiang W, Li DJ (2007) Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population. BMC Cancer 7:173

    Article  PubMed  Google Scholar 

  • Welsh MM, Applebaum KM, Spencer SK, Perry AE, Karagas MR, Nelson HH (2009) CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer. Cancer Res 69(15):6158–6163

    Article  PubMed  CAS  Google Scholar 

  • Wong YK, Chang KW, Cheng CY, Liu CJ (2006) Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma. J Oral Pathol Med 35(1):51–54

    Article  PubMed  CAS  Google Scholar 

  • Zhao B, Meng LQ, Huang HN, Pan Y, Xu QQ (2009) A novel functional polymorphism, 16974 A/C, in the interleukin-12–3’ untranslated region is associated with risk of glioma. DNA Cell Biol 28(7):335–341

    Article  PubMed  CAS  Google Scholar 

  • Zheng CY, Huang DR, Liu L, Bjorkholm M, Holm G, Yi Q, Sundblad A (2001) Cytotoxic T-lymphocyte antigen-4 microsatellite polymorphism is associated with multiple myeloma. Br J Haematol 112(1):216–218

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by China National Key Basic Research Program Grants (2002CB512902), National 211 Environmental Genomics Grant. We thank all the patients and individuals for their participation, the clinicians and other hospital staff, cancer registries, and study staff.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ying Mao or Daru Lu.

Additional information

Qihan Wu, Xiaoying Zhan, and Tonghai Dou contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, Q., Zhan, X., Dou, T. et al. CTLA4 A49G Polymorphism Shows Significant Association With Glioma Risk in a Chinese Population. Biochem Genet 49, 190–201 (2011). https://doi.org/10.1007/s10528-010-9398-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10528-010-9398-0

Keywords

Navigation